Author:
Marinò M.,Morabito E.,Altea M. A.,Ambrogini E.,Oliveri F.,Brunetto M. R.,Pollina L. E.,Campani D.,Vitti P.,Bartalena L.,Pinchera A.,Marcocci C.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference15 articles.
1. Bartalena L, Pinchera A, Marcocci C. Management of Graves’ ophthalmopathy: reality and perspectives. Endocr Rev 2000, 21: 168–99.
2. Bartalena L, Marcocci C, Tanda ML, et al. Orbital radiotherapy for Graves’ ophthalmopathy. Thyroid 2002, 12: 245–52.
3. Marcocci C, Bartalena L, Tanda ML, et al. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoid associated with orbital radiotherapy in the management of severe Graves’ ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endoc Metab 2001, 86: 3562–7.
4. Marcocci C, Marino M, Rocchi R, Menconi F, Morabito E, Pinchera A. Novel aspects of immunosuppressive and radiotherapy management of Graves’ ophthalmopathy. J Endocrinol Invest 2004, 27: 272–80.
5. Bartalena L, Marcocci C, Gorman CA, Wiersinga WM, Pinchera A. Orbital radiotherapy for Graves’ ophthalmopathy: useful or useless? Safe or dangerous? J Endocrinol Invest 2003, 26: 5–16.
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献